Preclinical Evaluation of M30 and M65 ELISAs as Biomarkers of Drug Induced Tumor Cell Death and Antitumor Activity

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-2136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search